Page last updated: 2024-12-09

1-phenyl-3-trifluoromethyl-5-hydroxypyrazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-Phenyl-3-trifluoromethyl-5-hydroxypyrazole: A Promising Scaffold for Drug Discovery

**1-Phenyl-3-trifluoromethyl-5-hydroxypyrazole** is a heterocyclic compound with a specific structure that has attracted significant attention in medicinal chemistry research.

**Key features of the molecule:**

* **Pyrazole ring:** This five-membered ring with two nitrogen atoms is a common structural motif in pharmaceuticals and agrochemicals.
* **Phenyl substituent:** The phenyl group adds to the molecule's lipophilicity and can interact with hydrophobic pockets on protein targets.
* **Trifluoromethyl group:** This group is known for its electron-withdrawing properties, which can influence the molecule's reactivity and biological activity.
* **Hydroxyl group:** This group can participate in hydrogen bonding interactions and is often involved in modulating the compound's acidity and solubility.

**Why is it important for research?**

This specific pyrazole derivative has shown promising biological activity in various research areas, including:

* **Anti-cancer agents:** Studies have shown that 1-phenyl-3-trifluoromethyl-5-hydroxypyrazole derivatives can exhibit significant anti-proliferative activity against various cancer cell lines. This suggests potential for developing novel anticancer drugs.
* **Anti-inflammatory agents:** The compound has also been found to possess anti-inflammatory properties, potentially due to its ability to modulate specific signaling pathways involved in inflammation.
* **Antimicrobial agents:** Some derivatives of this molecule have demonstrated antibacterial and antifungal activity, making them potential leads for developing new antibiotics and antifungals.

**Further Research Potential:**

The unique structural features of 1-phenyl-3-trifluoromethyl-5-hydroxypyrazole make it a versatile scaffold for further research and development. Scientists can modify the molecule by adding different substituents to the pyrazole ring, the phenyl group, or the hydroxyl group. This allows for the exploration of a broad range of potential therapeutic applications.

**Overall, 1-phenyl-3-trifluoromethyl-5-hydroxypyrazole represents a promising lead for the discovery and development of new pharmaceuticals with diverse biological activities.** The research into this compound continues to grow, highlighting its importance in the field of medicinal chemistry.

1-phenyl-3-trifluoromethyl-5-hydroxypyrazole: metabolite of flupyrazofos [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID892717
SCHEMBL ID537395
SCHEMBL ID486072
MeSH IDM0300460

Synonyms (37)

Synonym
HMS1590E01
96145-98-1
2-phenyl-5-trifluoromethyl-2h-pyrazol-3-ol
STK312844
1-phenyl-3-(trifluoromethyl)-1h-pyrazol-5-ol
SR-01000636391-1
MAYBRIDGE1_004315
AKOS000310728
HMS553M05
2-phenyl-5-(trifluoromethyl)-1h-pyrazol-3-one
5-hydroxy-1-phenyl-3-(trifluoromethyl)-1h-pyrazole
5-hydroxy-1-phenyl-3-trifluoromethylpyrazole
CCG-46714
2-phenyl-5-(trifluoromethyl)pyrazol-3-ol
FT-0649241
1-phenyl-3-trifluoromethyl-5-pyrazolone
SCHEMBL537395
1-phenyl-3-trifluoromethyl-5-hydroxypyrazole
1-phenyl-3-trifluoromethyl-1h-pyrazol-5-ol
mfcd03714773
SCHEMBL486072
CS-10775
AC-26699
sr-01000253389
SR-01000253389-1
DTXSID60358397
2-phenyl-5-(trifluoromethyl)-1,2-dihydro-3h-pyrazol-3-one
1-phenyl-3-trifluoromethylpyrazol-5-one
1-phenyl-3-[trifluoromethyl]-1h-pyrazol-5-ol
CS-0040063
1h-pyrazol-5-ol,1-phenyl-3-(trifluoromethyl)-
1h-pyrazol-5-ol, 1-phenyl-3-(trifluoromethyl)-
781-93-1
AMY11034
2-phenyl-5-(trifluoromethyl)-2,3-dihydro-1h-pyrazol-3-one
BBL039000
EN300-229754
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.69 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]